Development and utility of pirfenidone in the treatment of idiopathic pulmonary fibrosis: review of preclinical science and recent clinical trials
Transplant Research and Risk Management · 2011
DOI: 10.2147/trrm.s16205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Research and Risk Management, 2011. Verfasst von Robert Robert M Jackson und 1 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jackson, R. R. M., & Gomez-Marin, O. (2011). Development and utility of pirfenidone in the treatment of idiopathic pulmonary fibrosis: review of preclinical science and recent clinical trials. Transplant Research and Risk Management. https://doi.org/10.2147/trrm.s16205
Vancouver
Jackson RRM, Gomez-Marin O. Development and utility of pirfenidone in the treatment of idiopathic pulmonary fibrosis: review of preclinical science and recent clinical trials. Transplant Research and Risk Management. 2011. doi:10.2147/trrm.s16205
BibTeX
@article{Jackson2011,
author = {Jackson, Robert Robert M and Gomez-Marin, Orlando},
title = {Development and utility of pirfenidone in the treatment of idiopathic pulmonary fibrosis: review of preclinical science and recent clinical trials},
journal = {Transplant Research and Risk Management},
year = {2011},
doi = {10.2147/trrm.s16205}
}
EUVIMED